Lupin fell 0.68% to Rs 1,545 at 14:50 IST on BSE after consolidated net profit rose 26.32% to Rs 601.45 crore on 6.76% rise in total income to Rs 3261.04 crore in Q3 December 2014 over Q3 December 2013.
The Q3 result was announced during market hours today, 3 February 2015.
Meanwhile, the BSE Sensex was down 134.40 points, or 0.46%, to 29,009.96.
On BSE, so far 1.19 lakh shares were traded in the counter, compared with an average volume of 44,674 shares in the past one quarter.
The stock hit a high of Rs 1,576 and a low of Rs 1,523.55 so far during the day. The stock hit a record high of Rs 1,606 on 2 February 2015. The stock hit a 52-week low of Rs 885 on 3 February 2014.
The stock had outperformed the market over the past one month till 2 February 2015, rising 8.58% compared with 4.43% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 13.63% as against Sensex's 4.51% rise.
The large-cap pharma company has an equity capital of Rs 89.87 crore. Face value per share is Rs 2.
Powered by Capital Market - Live News
